Page 1447 - Williams Hematology ( PDFDrive )

1422 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1423

421. Still IH, Chernova O, Hurd D, et al: Molecular characterization of the t(8;13) (p11;q12) 454. Fouillard L, Labopin M, Gorin N-C, et al: Hematopoietic stem cell transplantation
translocation associated with an atypical myeloproliferative disorder: Evidence for for de novo erythroleukemia: A study of the European Group for Blood and Marrow
three discrete loci involved in myeloid leukemias on 8 p11. Blood 90:3136, 1997. Transplantation (EBMT). Blood 100:3135, 2002.
422. Ogura K, Kimura F, Kobayashi S, et al: Myeloid/NK cell precursor acute leukemia lost 455. Novick Y, Marino P, Makower DF, Wiernik PH: Familial erythroleukemia: A distinct
both CD13 and CD33 at first diagnosis. Leuk Res 30:761, 2006. clinical and genetic type of familial leukemia. Leuk Lymphoma 80:395, 1998.
423. Suzuki R, Suzumiya J, Nakamura S, et al: NK-cell Tumor Study Group. Hematopoi- 456. Lee EJ, Schiffer CA, Misawa S, Testa JR: Clinical and cytogenetic features of familial
etic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow erythroleukaemia. Br J Haematol 65:313, 1987.
Transplant 37:425, 2006. 457. Cuneo A, VanOrshoven A, Michaux JL, et al: Morphologic, immunologic and cytoge-
424. Mirro J, Kitchingman GR, Williams DL, Murphy SB: Mixed lineage leukemia: The netic studies in erythroleukemia: Evidence for multilineage involvement and identifi-
implication for hemopoietic differentiation [letter]. Blood 68:597, 1986. cation of two distinct cytogenetic clinicopathologic types. Br J Haematol 75:346, 1990.
425. Ladanyi M, Samaniego F, Reuter VE, et al: Cytogenetic and immunohistochemical 458. Goldberg SL, Noel P, Klumpp TR, Dewald GW: The erythroid leukemias. Am J Clin
evidence for the germ cell origin of a subset of acute leukemias associated with medi- Oncol 21:42, 1998.
astinal germ cell tumors. J Natl Cancer Inst 82:221, 1990. 459. Olopade OI, Thangavelu M, Larson RA, et al: Clinical, morphologic, and cytogenetic
426. DeMent, CR, Roth BJ, Heerema N, et al: Hematologic neoplasia associated with pri- characteristics of 26 patients with acute erythroblastic leukemia. Blood 80:2873, 1992.
mary mediastinal germ-cell tumors. Hum Pathol 21:699, 1990. 460. Davey FR, Abraham N Jr, Bronetto VL, et al: Morphologic characteristics of erythroleu-
427. Nichols CR, Roth BJ, Heerema N, et al: Hematologic neoplasia associated with pri- kemia (Acute myeloid leukemia; FAB-M6): A CALGB study. Am J Hematol 49:29, 1995.
mary mediastinal germ-cell tumors. N Engl J Med 322:1425, 1990. 461. Adamson JW, Finch CA: Erythropoietin and the regulation of erythropoiesis in di
428. Kiffer JD, Sandeman TF: Primary malignant mediastinal germ cell tumors: A study of Guglielmo’s syndrome. Blood 36:590, 1970.
eleven cases and a review of the literature. Int J Radiat Oncol Biol Phys 17:835, 1990. 462. Mitjavila MT, Villeval JL, Cramer P, et al: Effects of granulocyte-macrophage colony-
429. Nichols CR: Mediastinal germ cell tumors: Clinical features and biologic correlates. stimulating factor and erythropoietin on leukemic erythroid colony formation in
Chest 99:472, 1991. human early erythroblastic leukemias. Blood 70:965, 1987.
430. Brahmanday GR, Gheorghe G, Jaiyesimi IA, et al: Primary mediastinal germ cell 463. Mazella FM, Kowel-Vern A, Shrit MA, et al: Acute erythroleukemia evaluation of
tumor evolving into an extramedullary acute megakaryoblastic leukemia causing cord 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis.
compression. J Clin Oncol 26:4686, 2008. Am J Clin Pathol 110:590, 1998.
431. Kollmannsberger C, Beyer J, Droz JP, et al: Secondary leukemia following high cumu- 464. Breton-Gorius J: Phenotypes of blasts in acute erythroblastic and megakaryoblastic
lative doses of etoposide in patients treated for advanced germ cell tumors. J Clin leukemia—A review. Keio J Med 36:23, 1987.
Oncol 16:3386, 1998. 465. Peterson BA, Levine EG: Uncommon subtypes of acute nonlymphocytic leukemia:
432. Miettinen M, Kraszewska E, Sobin LH, Lasota J: A nonrandom association between Clinical features and management of FAB M5, M6 and M7. Semin Oncol 14:425, 1987.
gastrointestinal stromal tumors and myeloid leukemia. Cancer 112:645, 2008. 466. Croizat P, Favre-Gilly J: Les aspects du syndrome hémorrhagiue des leucémies. Sang
433. Miyazato H, Sono H, Nasiki Y, et al: Detection of myeloperoxidase gene expression 20:417, 1949.
by in situ hybridization in a case of granulocytic sarcoma associated with AML-M0. 467. Hillstad LK: Acute promyelocytic leukemia. Acta Med Scand 159:189, 1957.
Leukemia 14:1797, 2001. 468. LoCoco F, Nervi C, Avvisati G, Mandelli F: Acute promyelocytic leukemia: A curable
434. Testa U, Torelli GF, Riccioni R, et al: Human acute stem cell leukemia with multilin- disease. Leukemia 12:1866, 1998.
eage differentiation potential via cascade activation of growth factor receptors. Blood 469. Avvisati G, Lo Coco F, Mandelli F: Acute promyelocytic leukemia: Clinical and mor-
99:4534, 2002. phological features and prognostic factors. Semin Hematol 38:4, 2001.
435. Cuneo A, Ferrant A, Michaux JL, et al: Cytogenetic profile of minimally differentiated 470. Estey E, Thall P, Kantarjian H, et al: Association between increased body mass index
(FAB M0) acute myeloid leukemia: Correlation with clinicobiologic findings. Blood and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leuke-
85:3688, 1995. mia. Leukemia 11:1661, 1997.
436. Venditti A, Del Poeta G, Buccisano F, et al: Minimally differentiated acute myeloid 471. Wong O, Harris F, Yiying W, Hua F: A hospital-based case-control study of acute mye-
leukemia (AML M0): Comparison of 25 cases with other French-American-British loid leukemia in Shanghai: Analysis of personal characteristics, lifestyle and environ-
subtypes. Blood 89:621, 1997. mental risk factors by subtypes of the WHO classification. Regul Toxicol Pharmacol
437. Villamor N, Zarco M-A, Rozman M, et al: Acute myeloblastic leukemia with minimal 55:340, 2009
myeloid differentiation: Phenotypical and ultrastructural characteristics. Leukemia 472. Elliott MA(1), Letendre L, Tefferi A, et al: Therapy-related acute promyelocytic leuke-
12:1071, 1998. mia: Observations relating to APL pathogenesis and therapy. Eur J Haematol 88:237,
438. Roumier C, Eclache V, Imbert M, et al: M0 AML, clinical and biologic features of the 2012.
disease, including AML1 gene mutations. Blood 101:1277, 2003. 473. Golomb HM, Rowley JD, Vardiman J, et al: “Microgranular” acute promyelocytic leu-
439. Maruyami F, Stass SA, Estey EH, et al: Detection of AML1/ETO fusion transcript as kemia: A distinct clinical, ultrastructural, and cyto-genetic entity. Blood 55:253, 1980.
a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 8:40, 474. McKenna RW, Parkin J, Bloomfield C, et al: Acute promyelocytic leukaemia: A
1994. study of 39 cases with identification of a hyperbasophilic microgranular variant. Br J
440. Schoch C, Haase D, Haferlach T, et al: Fifty-one patients with acute myeloid leukemia Haematol 50:201, 1982.
and translocation t(8;21) (q22; q22): An additional deletion in 9q is an adverse prog- 475. Rovelli A, Biondi A, Rajnoldi AC, et al: Microgranular variant of acute promyelocytic
nostic factor. Leukemia 10:1288, 1996. leukemia in children. J Clin Oncol 10:1413, 1992.
441. Wang J, Wang M, Liu JM: Transformation properties of the ETO gene, fusion partner 476. Castoldi GL, Liso V, Speechia G, Thomasi P: Acute promyelocytic leukemia: Morpho-
in t(8;21) leukemias. Cancer Res 57:2951, 1997. logical aspects. Leukemia 8(Suppl 2):S27, 1994.
442. Watkins CH, Hall BE: Monocytic leukemia of the Naegeli and Schilling types. Am J 477. Umeda M, Nojima Z, Yamaguchi R, et al: Two cases of acute promyelocytic leukemia
Clin Pathol 10:387, 1940. with marked basophilia—A variant type of APL with the capability of differentiating
443. Huhn D, Twardzik L: Acute myelomonocytic leukemia and the French-American- into basophils. Rinsho Ketsueki 28:2004, 1987.
British classification. Acta Haematol 69:36, 1983. 478. Gotoh H, Murakani S, Oku N, et al: Translocation t(15;17) and t(9;14) (q34;q22) in
444. Scott CS, Morgan M, Limbert HJ, et al: Cytochemical, immunological and ANAE-i- a case of acute promyelocytic leukemia with increased number of basophils. Cancer
soenzyme studies in acute myelomonocytic leukaemia: A study of 39 cases. Scand J Genet Cytogenet 36:103, 1988.
Haematol 35:284, 1985. 479. Yu RQ, Huang W, Chen SJ, et al: A case of acute eosinophilic granulocytic leukemia
445. Bloomfield CD, Garson OM, Violin L, et al: t(1;3)(p36; q21) in acute nonlymphocytic with PML-RAR alpha fusion gene expression and response to all-trans retinoic acid.
leukemia: A new cytogenetic-clinicopathologic association. Blood 66:1409, 1985. Leukemia 11:609, 1997.
446. Creictzig U, Niederbiermann G, Kitter J, et al: Prognostic significance of eosinophilia 480. Invernizzi R, Iannone AM, Bernuzzi S, et al: Acute promyelocytic leukemia toluidine
in acute myelomonocytic leukemia in relation to induction treatment. Haematol blue subtype. Leuk Lymphoma 18(Suppl 1):57, 1995.
Blood Transfus 33:226, 1990. 481. Rowley JD, Golomb HM, Dogherty C: 15/17 translocation, a consistent chromosomal
447. Hoyle CF, Sherrington PD, Fischer P, Hayhoe FGT: Basophils in acute leukemia. J Clin change in acute promyelocytic leukaemia. Lancet 1:549, 1977.
Pathol 42:785, 1989. 482. Lavau C, Dejean A: The t(15;17) translocation in acute promyelocytic leukemia. Leu-
448. Pearson MG, Vardiman JW, LeBeau MM, et al: Increased numbers of marrow kemia 8:1615, 1994.
basophils may be associated with t(6;9) in ANLL. Am J Hematol 18:393, 1985. 483. Chen Y, Li S, Zhou C, et al: TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)
449. Alsabeh R, Byrnes RK, Slovak ML, Arber DA: Acute myeloid leukemia with t(6;9) (q26;q21) translocation of acute promyelocytic leukemia. Blood 124:936, 2014.
(p23;q34): Association with myelodysplasia, basophilia, and initial CD34 negative 484. Sainty D, Liso V, Cantu-Rajnoldi A, et al: A new morphologic classification system for
phenotype. Am J Clin Pathol 107:430, 1997. acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene
450. Copelli M: Di una emopatia sistemizzata rappresentata da una iperplasia eritroblas- rearrangements. Blood 96:1287, 2000.
tica (eritromatosis). Path Riv Quindicin 4:460, 1912. 485. Petti MC, Fazi F, Gentile M, et al: Complete remission through blast differentiation
451. DiGuglielmo G: Richerche di hematologia: I. Una casa di eritroleucemia. Folia Med in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies.
13:386, 1917. Blood 100:1065, 2002.
452. Moeschlin S: Erythroblastosen, erythroleukemien und erythroblastamien. Folia Hae- 486. de Thé H, Chomienne C, Lanotte M, et al: The t(15;17) translocation of acute promy-
matol (Frankf) 64:262, 1940. elocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed
453. Dameshek W: The Di Guglielmo syndrome. Blood 13:192, 1940. locus. Nature 347:558, 1990.

Kaushansky_chapter 88_p1373-1436.indd 1422 9/21/15 11:02 AM